Active Pharmaceutical Ingredient (API) Market In India 2026-2030

Description

The active pharmaceutical ingredient (API) market in india is forecasted to grow by USD 11797.2 mn during 2025-2030, accelerating at a CAGR of 7.4% during the forecast period. The report on the active pharmaceutical ingredient (API) market in india provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising domestic healthcare expenditure and prevalence of chronic conditions, growing emphasis on biosimilars manufacturing, expansion of global export demand and contract manufacturing sectors.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Market Scope
Base Year	2025
End Year	2030
Series Year	2026-2030
Growth Momentum	Accelerate
YOY 2026	6.9%
CAGR	7.4%
Incremental Value	$11797.2 mn

Technavio's active pharmaceutical ingredient (API) market in india is segmented as below:

By Manufacturing Type

Captive APIs
Contract APIs

By Type

Innovative APIs
Generic APIs

By Product Type

Prescription
Over-the-counter (OTC)

By Application

Cardiovascular diseases (CVDS)
Oncology
Infectious diseases
Diabetes
Others

Geography

APAC
- India

This study identifies the accelerated digitization and integration of artificial intelligence in process synthesis as one of the prime reasons driving the active pharmaceutical ingredient (API) market in india growth during the next few years. Also, structural pivot toward continuous manufacturing systems and advanced flow chemistry and strategic integration of sustainability and green chemistry principles in chemical synthesis will lead to sizable demand in the market.

The report on the active pharmaceutical ingredient (API) market in india covers the following areas:

Active pharmaceutical ingredient (API) market in india sizing
Active pharmaceutical ingredient (API) market in india forecast
Active pharmaceutical ingredient (API) market in india industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading active pharmaceutical ingredient (API) market in india vendors that include Aarti Industries Ltd., Alembic Pharmaceuticals Ltd., Aurobindo Pharma Ltd., Cambrex Corp., Cipla Inc., Divis Laboratories Ltd., Dr. Reddys Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Granules India Ltd., HIKAL Ltd., Ipca Laboratories, Jubilant Pharmova Ltd., Laurus Labs Ltd., Lupin Ltd., Neuland Laboratories, Piramal Pharma Solutions, Shilpa Medicare Ltd., Strides Pharma Ltd., Sun Pharmaceutical Industries, Syngene International Ltd.. Also, the active pharmaceutical ingredient (API) market in india analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR77512

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Country Market Characteristics
- Executive Summary - Chart on Market Segmentation by Manufacturing Type
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Product Type
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030

3 Market Landscape

3.1 Market ecosystem
3.2 Market characteristics
3.3 Value chain analysis

4 Market Sizing

4.1 Market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2025
4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

5.1 Active Pharmaceutical Ingredient (API) Market in India 2020 - 2024
- Historic Market Size - Data Table on Active Pharmaceutical Ingredient (API) Market in India 2020 - 2024 ($ million)
5.2 Manufacturing Type segment analysis 2020 - 2024
- Historic Market Size - Manufacturing Type Segment 2020 - 2024 ($ million)
5.3 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
5.4 Product Type segment analysis 2020 - 2024
- Historic Market Size - Product Type Segment 2020 - 2024 ($ million)
5.5 Application segment analysis 2020 - 2024
- Historic Market Size - Application Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

6.1 Impact of AI on active pharmaceutical ingredient (API) market in India
6.2 Impact of geopolitical conflicts on active pharmaceutical ingredient (API) market in India

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
7.7 Market condition

8 Market Segmentation by Manufacturing Type

8.1 Market segments
8.2 Comparison by Manufacturing Type
8.3 Captive APIs - Market size and forecast 2025-2030
8.4 Contract APIs - Market size and forecast 2025-2030
8.5 Market opportunity by Manufacturing Type
- Market opportunity by Manufacturing Type ($ million)

9 Market Segmentation by Type

9.1 Market segments
9.2 Comparison by Type
9.3 Innovative APIs - Market size and forecast 2025-2030
9.4 Generic APIs - Market size and forecast 2025-2030
9.5 Market opportunity by Type
- Market opportunity by Type ($ million)

10 Market Segmentation by Product Type

10.1 Market segments
10.2 Comparison by Product Type
10.3 Prescription - Market size and forecast 2025-2030
10.4 Over-the-counter (OTC) - Market size and forecast 2025-2030
10.5 Market opportunity by Product Type
- Market opportunity by Product Type ($ million)

11 Market Segmentation by Application

11.1 Market segments
11.2 Comparison by Application
11.3 Cardiovascular diseases (CVDs) - Market size and forecast 2025-2030
11.4 Oncology - Market size and forecast 2025-2030
11.5 Infectious diseases - Market size and forecast 2025-2030
11.6 Diabetes - Market size and forecast 2025-2030
11.7 Others - Market size and forecast 2025-2030
11.8 Market opportunity by Application
- Market opportunity by Application ($ million)

12 Customer Landscape

12.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

13 Drivers, Challenges, and Opportunity

13.1 Market drivers
- Rising domestic healthcare expenditure and prevalence of chronic conditions
- Growing emphasis on biosimilars manufacturing
- Expansion of global export demand and contract manufacturing sectors
13.2 Market challenges
- Margin compression from increasing costs of raw inputs and global price volatility
- Restrictive environmental compliance regimes and complex regulatory oversight
- Persistent structural reliance on foreign input material and core supply chains
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
13.4 Market opportunities
- Accelerated digitization and integration of artificial intelligence in process synthesis
- Structural pivot toward continuous manufacturing systems and advanced flow chemistry
- Strategic integration of sustainability and green chemistry principles in chemical synthesis

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 Aurobindo Pharma Ltd.
- Aurobindo Pharma Ltd. - Overview
- Aurobindo Pharma Ltd. - Business segments
- Aurobindo Pharma Ltd. - Key news
- Aurobindo Pharma Ltd. - Key offerings
- Aurobindo Pharma Ltd. - Segment focus
- SWOT
15.5 Cipla Inc.
- Cipla Inc. - Overview
- Cipla Inc. - Business segments
- Cipla Inc. - Key news
- Cipla Inc. - Key offerings
- Cipla Inc. - Segment focus
- SWOT
15.6 Divis Laboratories Ltd.
- Divis Laboratories Ltd. - Overview
- Divis Laboratories Ltd. - Product / Service
- Divis Laboratories Ltd. - Key offerings
- SWOT
15.7 Dr. Reddys Laboratories Ltd.
- Dr. Reddys Laboratories Ltd. - Overview
- Dr. Reddys Laboratories Ltd. - Business segments
- Dr. Reddys Laboratories Ltd. - Key news
- Dr. Reddys Laboratories Ltd. - Key offerings
- Dr. Reddys Laboratories Ltd. - Segment focus
- SWOT
15.8 Glenmark Pharmaceuticals Ltd.
- Glenmark Pharmaceuticals Ltd. - Overview
- Glenmark Pharmaceuticals Ltd. - Product / Service
- Glenmark Pharmaceuticals Ltd. - Key news
- Glenmark Pharmaceuticals Ltd. - Key offerings
- SWOT
15.9 Granules India Ltd.
- Granules India Ltd. - Overview
- Granules India Ltd. - Product / Service
- Granules India Ltd. - Key offerings
- SWOT
15.10 Ipca Laboratories
- Ipca Laboratories - Overview
- Ipca Laboratories - Product / Service
- Ipca Laboratories - Key offerings
- SWOT
15.11 Jubilant Pharmova Ltd.
- Jubilant Pharmova Ltd. - Overview
- Jubilant Pharmova Ltd. - Business segments
- Jubilant Pharmova Ltd. - Key offerings
- Jubilant Pharmova Ltd. - Segment focus
- SWOT
15.12 Laurus Labs Ltd.
- Laurus Labs Ltd. - Overview
- Laurus Labs Ltd. - Product / Service
- Laurus Labs Ltd. - Key offerings
- SWOT
15.13 Lupin Ltd.
- Lupin Ltd. - Overview
- Lupin Ltd. - Business segments
- Lupin Ltd. - Key news
- Lupin Ltd. - Key offerings
- Lupin Ltd. - Segment focus
- SWOT
15.14 Piramal Pharma Solutions
- Piramal Pharma Solutions - Overview
- Piramal Pharma Solutions - Business segments
- Piramal Pharma Solutions - Key offerings
- Piramal Pharma Solutions - Segment focus
- SWOT
15.15 Shilpa Medicare Ltd.
- Shilpa Medicare Ltd. - Overview
- Shilpa Medicare Ltd. - Product / Service
- Shilpa Medicare Ltd. - Key offerings
- SWOT
15.16 Strides Pharma Ltd.
- Strides Pharma Ltd. - Overview
- Strides Pharma Ltd. - Product / Service
- Strides Pharma Ltd. - Key offerings
- SWOT
15.17 Sun Pharmaceutical Industries
- Sun Pharmaceutical Industries - Overview
- Sun Pharmaceutical Industries - Business segments
- Sun Pharmaceutical Industries - Key news
- Sun Pharmaceutical Industries - Key offerings
- Sun Pharmaceutical Industries - Segment focus
- SWOT
15.18 Syngene International Ltd.
- Syngene International Ltd. - Overview
- Syngene International Ltd. - Product / Service
- Syngene International Ltd. - Key offerings
- SWOT

16 Appendix

16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations